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Background/aims. Postprandial hyperglycemia, an independent risk factor for cardiovascular disease, is accompanied by endothe-
lial dysfunction. We studied the eﬀect of oral glucose load on insulin and glucose ﬂuctuations, and on postprandial endothelial
function in healthy individuals in order to better understand and cope with the postprandial state in insulin resistant individuals.
Methods. We assessed post-oral glucose load endothelial function (ﬂow mediated dilation), plasma insulin, and blood glucose in 9
healthy subjects. Results. The largest increases in delta FMD values (fasting FMD value subtracted from postprandial FMD value)
occurred at 3 hours after both glucose or placebo load, respectively: 4.80±1.41 ( P = .009) and 2.34±1.47 ( P = .15). Glucose and
insulin concentrations achieved maximum peaks at one hour post-glucose load. Conclusion. Oral glucose load does not induce
endothelial dysfunction in healthy individuals with mean insulin and glucose values of 5.6mmol/L and 27.2mmol/L, respectively,
2 hours after glucose load.
Copyright © 2008 A. Major-Pedersen et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Postprandial hyperglycemia is an independent risk factor for
cardiovascular disease (CVD) in insulin-resistant individuals
with type 2 diabetes or with the prediabetic state, impaired
glucose tolerance (IGT) [1–10]. In line with these epidemi-
ologic data, several studies have shown impairment of en-
dothelial function, one of the earliest markers of atheroscle-
rosis [11] after a meal or glucose challenge, in individuals
with diabetes or IGT [12–17].
Endothelial function following acute hyperglycemia has
also been studied in healthy individuals. Some groups
have shown attenuation of endothelial function [18–26],
whereas others have shown no change [27–31]. A few
studies have shown acute hyperglycemia induced vasodi-
lation in healthy individuals [32, 33], and only 2 stud-
ies (in vitro/ex vivo studies) have speciﬁcally reported glu-
cose induced enhancement of the endothelial function [34,
35].
These seemingly conﬂicting results could be attributed to
diﬀerences in methodology and subject characteristics: di-
verging periods of post-glucose load observations, varying
periods of exposition to diﬀerent concentrations of glucose,
diverging criteria in subject selection, enabling versus block-
ing insulin’s physiologic response, and ﬁnally administrating
oral glucose load versus intra-arterial or intravenous glucose
administration.
Endothelial dysfunction is a predictor of cardiovascu-
lar risk; consequently, postprandial endothelial dysfunction
might be a very early marker of atherosclerosis and, thus,
an early potential target for the prevention of cardiovascu-
lar complications in insulin resistance. In order to better un-
derstandandcopewithpostprandialendothelialdysfunction
and accompanying postprandial hyperinsulinemia and hy-
perglycemiaininsulinresistantindividuals,weﬁnditimpor-
tant to study postprandial glucose and insulin ﬂuctuations
and postprandial endothelial function in healthy, insulin-
sensitive people.2 Experimental Diabetes Research
Table 1: Subject characteristics. Data are presented as mean value
± SEM.
Variable (n = 10)
Age (years) 41.1 ±3.0
Gender (F/M) 4/6
Bo dy mass index (kg/m2)2 3 .2 ±0.71
Waist circumference (cm) 80.7 ±2.9
Glucose-fasting (mmol/l) 4.12 ±0.12
Glucose-2 hour post-glucose load (mmol/l) 5.58 ±0.32
P-fasting insulin (μU/ml) 2.96 ±0.37
HbA1c(%) 5.06 ±0.2
P-fasting triglycerides (mmol/l) 0.75 ±0.1
P-CRP (mg/l) 1.14 ±0.1
HOMA (kg/m2)0 .65 ±0.09
2. MATERIAL AND METHODS
2.1. Studypopulation
Ten non-smoking subjects, with no history of cardiovascular
or other chronic disease, with no signs of current acute dis-
ease, and no familiar disposition to glucose intolerance, were
included after screening a total of 13 individuals. We assessed
blood pressure, ECG, oral glucose tolerance test, calculations
of body mass index (BMI) and homeostasis model assess-
ment (HOMA), and biochemical parameters. Three subjects
were excluded: two due to total cholesterol > 6 mmo/L and
one due to history of anorexia nervosa. Participants’ char-
acteristics are shown on Table 1. All subjects gave written
informed consent and the study was approved by the ethics
committee for Copenhagen and Frederiksberg counties.
2.2. Studydesign
Cross over study, n = 10. Subjects met on 2 separate days at
8:00 am after a 12-hour fast and after at least 18 hours absti-
nence from exercise. On the “glucose day”, endothelial func-
tion was measured before a 75g oral glucose load (200mL)
and again at 1, 2, 3, and 4 hours after glucose load. On
the “placebo day”, the same procedure was followed, but the
75g glucose was substituted with placebo (200mL tap wa-
ter) as shown in Figure 1. The ﬁrst FMD measurement of the
day commenced between 8:30 and 9:00 am, glucose/H20w a s
given between 9:00 and 9:30, and the last FMD measurement
of the day ended between 13:30 and 14:00.
We extrapolated our post-glucose load ﬁndings to post-
prandial eﬀects, since plasma glucose concentrations mea-
sured 2 hours after the ingestion of 75g glucose have been
found to be closely related to those measured after a stan-
dardized mixed meal [36].
2.3. Measurementsofendothelialfunction
We used the flow mediated dilation (FMD) method [37, 38].
20 minutes after supine rest, a pneumatic cuﬀ was placed
distal to the antecubital fossa, a 7.5MHz linear array trans-
0 hour 1 hour 2 hours 3 hours 4 hours
FMD0 FMD1 FMD2 FMD3 FMD4
Glucose/
placebo load
Figure 1: Flow chart showing the study sequence during a study
day. FMD1, FMD2, FMD3, and FMD4, respectively. Flow mediated
dilation study at 1, 2, 3, and 4 hours after glucose/placebo load.
FMD0, ﬂow mediated dilation study before glucose/placebo load.
ducer (Cypress/Siemens, Siemens Medical Solutions USA,
Inc. Mountain View, CA) was placed proximal to the an-
tecubital fossa, and the brachial artery was viewed in a 2-
dimensional(B-mode)longitudinalplane.Abaselinepicture
was saved to ensure that the same brachial picture was found
in the successive studies. After acquiring a two-minute base-
line image, the cuﬀ was rapidly inﬂated to 300mmHg (VBM
tourniquets, Braun Scandinavia) for 5 minutes, followed by
rapid cuﬀ deﬂation. Images were registered during 4 minutes
after cuﬀ deﬂation. Brachial diameters (at baseline and after
cuﬀ-deﬂation) were measured simultaneously by automated
software (VIA online ﬂow mediated dilation software, MD
Medic) [39]. This software enabled us to precisely localize
the greatest EDV since dilation was depicted graphically (as
well as numerically).
The following formula was used to calculate relative
change in FMD (expressed in %): ((Peak post cuﬀ-deﬂation
diameter − basline diameter)/baseline diameter) ×100 [40].
An intravenous cannula was inserted into a large antecu-
bital vein in the left arm for blood sampling.
2.4. Biochemicalmeasurements
Blood samples were drawn on both days before oral glu-
cose load/placebo administration and at 15, 30, 60, 120, 180,
and 240 minutes after plasma was separated after complete
clot formation, subsequent to centrifugation, and thereafter
frozen at −80◦C for posterior analysis of insulin (Immulite
2000, DPC Scandinavia, Denmark).
Whole venous blood glucose was measured at the afore-
mentioned times with HemoCue glucose (HemoCue AB,
Angelholm, Sweden).
2.5. Dataanalysis
Data are presented as mean ± SEM. Comparisons between
time points on the same curve (pre-oral glucose load, 1hPG,
2hPG, 3hPG, and 4hPG) for FMD, insulin, and glucose were
evaluated with paired student t test for each curve sepa-
rately. The level of statistical signiﬁcance used was P < .05.
For comparison of FMD time response studies between the
2 curves (post-glucose curve versus post-placebo curve), we
used MIXED MODEL analysis (SAS statistical software ver-
sion 9.1, SAS Institute, Cary, NC, USA).
Model assumptions of homogeneity of variance and
normal distribution of residuals were checked graphically.A. Major-Pedersen et al. 3
Subjects entered the model as random eﬀect as did the in-
teraction between subject and time. Time and experimental




Delta FMD values (fasting FMD value subtracted from post-
prandial FMD value) ± SEM for post-glucose load and post-
placebo load showed increasing FMD delta values for both
days (see Table 2). The largest post-glucose load increase oc-
curredat3hPG(P =.009);comparedtobaseline,theincrease
was already signiﬁcant at 1hPG (P = 0.03). The largest post-
placebo increase also occurred at 3 hours post-placebo (P =
.15)butwasnotsigniﬁcant(seeTable 2).Whenwecompared
the two curves employing mixed models (post-glucose load
curve versus post-placebo load curve), we found the curves
to be statistically diﬀerent (P = .0007).
3.2. Metabolicparameters
3.2.1. Glucose
Post-glucose load mean blood glucose concentration values
showed a signiﬁcant increase at both 1hPG (P = .03) and
2hPG (P = .002). Conversely, a signiﬁcant fall in blood sugar
w a so b s e r v e da t4 h P G( P = .002, n = 6 since the study was
interrupted before the fourth postprandial hour in 3 sub-
jects due to symptomatic hypoglycemia). As expected, post-
placebo load values showed no signiﬁcant change in blood
glucose concentrations in the fasting state (see Table 2).
3.2.2. Insulin
Mean insulin concentration post-glucose load values showed
a marked increase at 1hPG (P = .0006) and fell rapidly
thereafter, achieving pre-glucose-like values by 3hPG. Post-
placebo load values fell across the 4 hour post-load period,
which was already apparent at one hour post placebo load (P
= .0006) (Table 2).
4. DISCUSSION
Our principal ﬁnding was that oral glucose load did not im-
pair endothelial function in conduit arteries in our group
of healthy, insulin-sensitive individuals with mean 2hPG of
5.58mmol/L. We found maximum glucose and insulin peak
concentrations at 1hPG. Furthermore our ﬁndings imply
that oral glucose load might enhance endothelial function in
these individuals.
Many studies have examined the eﬀect of acute hyper-
glycemia on the healthy endothelium [18, 20, 22, 23, 30, 41].
These studies, however, cannot be directly compared to
ours since both the methodology and the purpose of the
studies diverge from our study. The aforementioned stud-
ies demonstrated that hyperglycemia induced impaired en-
dothelial function, in healthy individuals, by either apply-
ing a local glucose/dextrose clamp or by intra-arterial glu-
coseinfusion,henceobtainingelevatedhyperglycemicvalues
(7.0 to 16.7mmol/L). Yet, postprandial hormonal mecha-
nisms, such as those leading to the “incretin eﬀect”[42], may
not be triggered when examined through the hyperglycemic
clamp technique or local hyperglycemia. Some of these stud-
ies [30, 41] had also administered systemic ocreotide to sup-
press insulin secretion response to hyperglycemia. We did
not ﬁnd it appropriate to inhibit insulin secretion in order to
study the physiologic endothelial post-glucose load response
in healthy individuals since we suspected that the post-oral-
glucose load insulin response might be pivotal in contribut-
ing to endothelial dependent vasodilation. Aside from keep-
ing all hormonal responses intact, we chose to investigate
post-glucose load endothelial function up to 4 hours af-
ter glucose load, because we were aware of the possibility
that the endothelial response might not necessarily occur si-
multaneously with the increasing glucose and insulin con-
centrations. Our study is further strengthened by the fact
that “time to peak” (the time it takes to achieve maximal
dilation after cuﬀ-deﬂation) varies individually, and that,
by using our automated edge-detecting software, we have
been sure of appreciating the largest dilation at each FMD
measurement. Earlier studies using the FMD method have
been forced to ﬁnd a spot more or less blindly, between 40
and 90 seconds post cuﬀ-deﬂation, for their measurements
[19, 25].
As mentioned, diﬀerences in subject selection, particu-
larly regarding postprandial blood glucose concentrations,
might too have contributed to the apparently diverse ﬁnd-
ings reported in our study and other studies. A continuous
relationshipbetweenincreasingfastingandpostprandialglu-
cose concentrations and the risk of cardiovascular mortal-
ity in healthy, normoglycemic subjects has been documented
[9, 43, 44]. Furthermore, a strong inverse relationship has
been demonstrated between glucose levels, and endothe-
lial function and intima media thickness (IMT) across the
normoglycemic continuum; this was marked already at the
5.2mmol/cut-oﬀ, and was even more signiﬁcant with fast-
ing glucose above 5.7mmol/L [45]. Interestingly, a directly
proportional risk gradient between CVD and postprandial
glucose has been evidenced at1hPG [9].
In accordance with our selection criteria, our subjects
were metabolic healthier, with lower mean fasting and post-
prandialglucosevaluesthanthoseinstudieswhichemployed
a methodology similar to ours and, yet, demonstrated im-
paired endothelial function [21, 25, 26]. To illustrate, Ti-
tle’s study [19] reported impaired endothelial function after
oral glucose loading in 10 study subjects with a mean 1hPG
of 7.9mmol/L (as opposed to 6.2mmol/L in our subjects).
Thereby, the apparently contradictory results between Title’s
study and ours are actually complementary.
A limitation to our study is that it does not shed light
on the cellular mechanisms responsible for the postpran-
dial endothelial response. Yet, several mechanistic studies
support our ﬁndings. Taubert’s group [34], for example,
demonstrated that insulin’s NO vasodilatory eﬀect was aug-
mented in the presence of relative hyperglycemia [34]. In-
deed,inoursubjects,therewasashortandmodestpostpran-
dial plasma glucose spike, followed by a larger postprandial4 Experimental Diabetes Research
Table 2: Eﬀects of glucose load and placebo load on FMD, blood glucose and plasma insulin. Data are presented as mean value ± SEM.
Times Delta FMD (%) Blood Glucose (mmol/l) Plasma Insulin (μU/l)
Glucose load Placebo load Glucose load Placebo load Glucose load Placebo load
Pre-load 0 0 4.12 ±0.12 4.46 ±0.17 2.96 ±0.37 4.24 ±0.67
1h 2.10 ±0.84 0.19 ±0.70 6.21 ±0.79 4.54 ±0.15 34.42 ±4.99 3.30 ±0.55
2h 0.65 ±0.85 1.66 ±0.84 5.58 ±0.32 4.64 ±0.19 27.24 ±3.03 2.89 ±0.48
3h 4.80 ±1.42 .34 ±1.47 4.23 ±0.37 4.53 ±0.17 12.67 ±2.54 3.44 ±0.82
4h 2.0 ±1.39 0.9 ±1.44 3.35 ±0.17 4.27 ±0.18 4.81 ±0.88 2.90 ±0.58
hyperinsulinemic spike, which, in conjunction, led to an en-
hancement of the endothelial function when compared to
baseline endothelial function. Conversely, our group [46]
has previously proposed that persistent hyperglycemia in-
hibits PI3K-dependent signaling. Taubert’s group reported
that glucose and insulin stimulated NO release was impaired
in the presence of hyperglycemia lasting beyond 2 hours, and
that acute hyperglycemia did not increase NO release after
prolonged exposure to hyperglycemia, leading them to sug-
gest that enhanced superoxide generation in chronic hyper-
glycemia could be responsible for accelerated NO degrada-
tion. These ﬁndings could explain why studies where hyper-
glycemic clamps were employed, and/or examined subjects
with relatively high postprandial values, have not found en-
hanced endothelial function [18–20, 23, 30, 47].
The greatest increment in endothelial function in our
study occurred at 3 hours post-glucose load when glucose
concentrations were back to baseline levels yet with in-
sulin concentrations still 6 times higher than baseline in-
sulin concentrations. Furthermore we observed a positive
post-glucose load delta value at the cessation of the study
(4hPG) for FMD and insulin concentrations. Interestingly,
Cardillo et al. [48] found maximal insulin dilator eﬀect af-
ter 2 hours of insulin infusion, leading them to postulate
that insulin has a relatively slow-onset vasodilator eﬀect. Ac-
cordingly, four hours of sustained hyperinsulinemia in the
healthy has been shown to induce endothelial dependent va-
sodilation [49]. These observations could therefore explain
our positive ﬁndings and why research groups that have lim-
ited their postprandial endothelial studies to 2 hours or less
after a meal/glucose load [24] have not observed insulin in-




centrations; yet we cannot directly compare our results with
studies that have used standardized meals since these include
lipids. Admitting that a standardized meal would have re-
ﬂected a truer postprandial response, a standardized meal
would have obscured the action of glucose alone on the en-
dotheliuem, since it has been demonstrated that postpran-
dial hyperlipidemia induces postprandial endothelial dys-
function in the healthy endothelium [50–52].
5. CONCLUSION
In short, we ﬁnd that endothelial dysfunction is not a nor-
mal, physiologic, post-glucose load response. Instead, this
studyﬁndspreservedpost-glucoseloadendothelialfunction,
thus implying that sugar derived from meals does not pro-
mote endothelial dysfunction, providing that postprandial
insulin and glucose responses are preserved. It seems that the
interaction of glucose and insulin on the endothelial func-
tion is aﬀected both by the magnitude of glucose and insulin
concentrations, and by the duration of exposition to these.
The immediate question arising from this study is
whether by targeting both postprandial glucose and insulin
peaks in insulin resistant individuals, so that both postpran-
dial peaks resemble those of insulin sensitive individuals, en-
hances postprandial endothelial function. There is a pressing
needforagreatertherapeuticfocusonthepostprandialstate,
accompanied by a redeﬁnition of the “normal” postprandial
state, marking the true threshold for the onset of cardiovas-
cular risk.
ABBREVIATIONS
1hPG, 2hPG: 1-hour and 2-hour glucose values after
an oral 75 glucose load
3hPG, 4hPG: 3-hour and 4-hour glucose values after
an oral 75 glucose load
CVD: Cardiovascular disease
FMD: Flow mediated dilation
HOMA: Homeostasis model assessment
IGT: Impaired glucose tolerance
NO: Nitric oxide
PI3K: Phsophatidylnositol 3 -OH kinase
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